Related Experiment Videos
Dose-volume and complication in interstitial implants for breast carcinoma
Summary
This study found that larger treated breast tissue volumes in radiotherapy correlate with higher risks of soft tissue complications. Dose-volume analysis can predict complication probability in breast cancer patients receiving interstitial iridium-192 boosts.
Area of Science:
- Radiation Oncology
- Medical Physics
- Breast Cancer Treatment
Background:
- External beam radiation combined with interstitial iridium-192 boosts is common for breast cancer.
- Smaller tumors (T1-T2) have low complication rates with this technique.
- Advanced stages require larger volumes and higher doses, increasing complication incidence.
Purpose of the Study:
- To investigate dose-volume relationships in interstitial breast radiotherapy.
- To correlate these relationships with soft tissue radiation injury risk.
- To offer a method for clinical evaluation of interstitial implants.
Main Methods:
- Retrospective analysis of 111 breast cancer patients (5 with complications, 51 without).
- Calculation of tissue volumes enclosed by isodose surfaces (10-50 Gy).
- Development of a complication probability curve using a linear logistic model based on the 20 Gy isodose surface.
Main Results:
- Mean tissue volume at specified dose levels was significantly higher (p<0.05) in patients with complications.
- A complication probability versus dose-volume curve, using the 20 Gy isodose surface, closely fitted the data (p<0.006).
- Calculated treatment volume effectively separates patients by complication probability.
Conclusions:
- Dose-volume analysis is a viable method for assessing soft tissue complication risk in interstitial breast radiotherapy.
- This method can be used for clinical risk assessment and inter-institutional comparisons.
- Treatment volume within the 20 Gy isodose surface predicts complication probability.